Science & Technology
Trans Spinal Delivery of a Targeted Nanoformulation of Curcuminoids to Treat AD
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R41AG085737-01
Award Ceiling
$506K
Award Floor
$506K
Close Date
Aug 31, 2025
Total Funding
$506K
Expected Awards
1
Posted Date
Sep 25, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-1R41AG085737-01
Description
STTR Phase Phase I award: "Trans Spinal Delivery of a Targeted Nanoformulation of Curcuminoids to Treat AD" awarded to 3P BIOTECHNOLOGIES, INC. in PROSPECT, Kentucky. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $506,464. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.